VisCardia Completes $12.5 Million Series B Financing and Assets Transfer to Develop Proprietary Therapeutic Heart Failure Application and Appoints Michael Mirro M.D. as Director of Medical Affairs
PORTLAND, Ore.--(Healthcare Sales & Marketing Network)--VisCardia Inc, a privately held medical device developer, announced today it has completed series B financing and simultaneously obtained assets and technology rights from Inovise Medical, Inc., with ... Devices, Cardiology, Venture Capital, Personnel VisCardia, Inovise Medical, heart failure
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Failure | Marketing | Medical Devices | Pharmaceuticals | Venture Capital